This case was received by bioventus on december 5, 2022 and it was forwarded to the manufacturer on december 8.This case was filed to the fda on december 27 from the manufacturer and also filed on december 30 from bioventus as 3009595577-2022-00006.No update was provided from the follow up.Dates of the follow up attempts were the followings; dec 7th - email follow up sent to the rep, dec 19th - fax sent to the physician's office, dec 19th - phone call place to sales rep, dec 20th - email sent to follow up with physician, dec 30th - phone call placed to the physician's office.
|